3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
15
Phase 1
3
Phase 2
2
Phase 4
1
Phase 1/2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Genitourinary
1
Conditions
Multiple Myeloma
25
Leukemia, Myeloid, Acute
24
Lymphoma
22
Breast Neoplasms
20
Prostatic Neoplasms
15
Melanoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Colorectal Neoplasms
14
Lung Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Neoplasm Metastasis
12
Myelodysplastic Syndromes
12
Lymphoma, Large B-Cell, Diffuse
12
Squamous Cell Carcinoma of Head and Neck
11
Pancreatic Neoplasms
11
Ovarian Neoplasms
10
Myeloproliferative Disorders
10
Triple Negative Breast Neoplasms
8
Rectal Neoplasms
8
Leukemia, Myelomonocytic, Chronic
8
Carcinoma, Renal Cell
8
Burkitt Lymphoma
8
Sarcoma
7
Lymphoma, Follicular
7
Colonic Neoplasms
7
Urinary Bladder Neoplasms
6
Lymphoma, Non-Hodgkin
6
Glioma
6
Fallopian Tube Neoplasms
6
Cholangiocarcinoma
6
Interventions
Gemcitabine
53
Bevacizumab
52
Cyclophosphamide
49
Docetaxel
42
Carboplatin
40
pembrolizumab
37
Paclitaxel
36
Fluorouracil
36
Cisplatin
35
Radiotherapy
31
Oxaliplatin
31
Capecitabine
29
Irinotecan
28
Dexamethasone
27
Leucovorin
25
Cetuximab
25
Nivolumab
24
Doxorubicin
22
Drug Therapy
21
Erlotinib Hydrochloride
20
Pemetrexed
19
durvalumab
18
trametinib
17
fludarabine
16
atezolizumab
16
Trastuzumab
16
Sunitinib
16
Rituximab
16
Prednisone
16
Sorafenib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasms
×
Biopsy
×
Clear all
NCT01198119
2026-03-16
NBI-CAB
Centre Oscar Lambret
Phase 2
Terminated
23 enrolled
NCT05655715
2024-10-16
CheckPRO
Herlev and Gentofte Hospital
Phase 2
Completed
90 enrolled